1284570

Coherus Oncology, Inc. — FEI 3009682611

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 9, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Redwood City, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)